April 28, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

  Рет қаралды 11,545

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

The committee will discuss supplemental new drug application (sNDA) 208558/S-025, for LYNPARZA (olaparib) tablets, submitted by AstraZeneca Pharmaceuticals LP. The proposed indication (use) for this product is in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC).

Пікірлер
Oncologic Drugs Advisory Committee Meeting
6:04:50
U.S. Food and Drug Administration
Рет қаралды 23 М.
September 26, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
9:00:31
U.S. Food and Drug Administration
Рет қаралды 14 М.
Жездуха 41-серия
36:26
Million Show
Рет қаралды 5 МЛН
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
6:49:31
U.S. Food and Drug Administration
Рет қаралды 13 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two
1:42:25
U.S. Food and Drug Administration
Рет қаралды 628
March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
9:08:15
U.S. Food and Drug Administration
Рет қаралды 19 М.
March 14, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
6:32:15
U.S. Food and Drug Administration
Рет қаралды 11 М.
November 16, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
5:20:45
U.S. Food and Drug Administration
Рет қаралды 5 М.
March 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
5:53:55
U.S. Food and Drug Administration
Рет қаралды 11 М.
FDA's Rare Disease Day 2024-Dedicated to Patients and Providers
7:34:28
U.S. Food and Drug Administration
Рет қаралды 6 М.
March 5, 2024 Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC)
8:34:46
U.S. Food and Drug Administration
Рет қаралды 2,5 М.
FDA-MHRA-HC 2024 Joint Symposium (Day 1)
7:06:50
U.S. Food and Drug Administration
Рет қаралды 17 М.
August 2, 2024 Meeting of the Genetic Metabolic Diseases Advisory Committee (GeMDAC)
8:30:00
U.S. Food and Drug Administration
Рет қаралды 4,9 М.
Жездуха 41-серия
36:26
Million Show
Рет қаралды 5 МЛН